Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
International Journal of Oncology
|
February 15, 2001
Retinoic acid and extracellular matrix inhibition of matrix metalloproteinase 9 expression is mediated by the mitogen activated protein kinase pathway
K J Tsang, D L Crowe
IUBMB Life
|
May 1, 2001
Characterization of a retinoic acid responsive element in the human ets-1 promoter
E N So, D L Crowe
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
August 26, 1998
Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines
D L Crowe, C F Shuler
Neoplasia (New York, N.Y.)
|
August 10, 2000
Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion
D L Crowe, T N Brown
Biochimica Et Biophysica Acta
|
March 27, 2001
Rb and E2F-1 regulate telomerase activity in human cancer cells
D L Crowe, D C Nguyen
Oncogene
|
December 22, 2015
Tumor suppressor control of the cancer stem cell niche
K Kramer, J Wu, D L Crowe
Histology and Histopathology
|
March 17, 2004
Relationships between stem cells and cancer stem cells
D L Crowe, B Parsa, U K Sinha
Neoplasia (New York, N.Y.)
|
April 28, 2001
Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression
D L Crowe, K J Tsang, B Shemirani
Anticancer Research
|
December 22, 1998
Anti-Fas antibody differentially regulates apoptosis in Fas ligand resistant carcinoma lines via the caspase 3 family of cell death proteases but independently of bcl2 expression
D L Crowe, M L Boardman, K S Fong
Molecular Carcinogenesis
|
June 3, 1998
Tumor suppressor function of a dominant negative retinoic acid receptor mutant
D L Crowe, U E Osaseri, C F Shuler
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
International Journal of Oncology
|
February 15, 2001
Retinoic acid and extracellular matrix inhibition of matrix metalloproteinase 9 expression is mediated by the mitogen activated protein kinase pathway
K J Tsang, D L Crowe
IUBMB Life
|
May 1, 2001
Characterization of a retinoic acid responsive element in the human ets-1 promoter
E N So, D L Crowe
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
August 26, 1998
Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines
D L Crowe, C F Shuler
Neoplasia (New York, N.Y.)
|
August 10, 2000
Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion
D L Crowe, T N Brown
Biochimica Et Biophysica Acta
|
March 27, 2001
Rb and E2F-1 regulate telomerase activity in human cancer cells
D L Crowe, D C Nguyen
Oncogene
|
December 22, 2015
Tumor suppressor control of the cancer stem cell niche
K Kramer, J Wu, D L Crowe
Histology and Histopathology
|
March 17, 2004
Relationships between stem cells and cancer stem cells
D L Crowe, B Parsa, U K Sinha
Neoplasia (New York, N.Y.)
|
April 28, 2001
Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression
D L Crowe, K J Tsang, B Shemirani
Anticancer Research
|
December 22, 1998
Anti-Fas antibody differentially regulates apoptosis in Fas ligand resistant carcinoma lines via the caspase 3 family of cell death proteases but independently of bcl2 expression
D L Crowe, M L Boardman, K S Fong
Molecular Carcinogenesis
|
June 3, 1998
Tumor suppressor function of a dominant negative retinoic acid receptor mutant
D L Crowe, U E Osaseri, C F Shuler
Page
of 4